EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

NAD+ Precursors and Intestinal Inflammation: Therapeutic Insights Involving Gut Microbiota

Julia Niño-Narvión iD, Marina Idalia Rojo-López iD, Patricia Martinez-Santos, Joana Rossell iD, Antonio J Ruiz-Alcaraz iD, Núria Alonso, Bruno Ramos-Molina iD, Didac Mauricio iD, Josep Julve iD

Nutrients · 30.06.2023 · 15 (13) · 2992

DOI: 10.3390/nu15132992 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 30.06.2023. Verfasst von Julia Niño-Narvión und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institut d'Investigació Biomèdica Sant Pau (IIB Sant Pau), 08041 Barcelona, Spain. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 151 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III (Madrid, Spain), Miguel Servet Type I” program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The oxidized form of nicotinamide adenine dinucleotide (NAD+) is a critical metabolite for living cells. NAD+ may act either as a cofactor for many cellular reactions as well as a coenzyme for different NAD+-consuming enzymes involved in the physiological homeostasis of different organs and systems. In mammals, NAD+ is synthesized from either tryptophan or other vitamin B3 intermediates that act as NAD+ precursors. Recent research suggests that NAD+ precursors play a crucial role in maintaining the integrity of the gut barrier. Indeed, its deficiency has been associated with enhanced gut inflammation and leakage, and dysbiosis. Conversely, NAD+-increasing therapies may confer protection against intestinal inflammation in experimental conditions and human patients, with accumulating evidence indicating that such favorable effects could be, at least in part, mediated by concomitant changes in the composition of intestinal microbiota. However, the mechanisms by which NAD+-based treatments affect the microbiota are still poorly understood. In this context, we have focused specifically on the impact of NAD+ deficiency on intestinal inflammation and dysbiosis in animal and human models. We have further explored the relationship between NAD+ and improved host intestinal metabolism and immunity and the composition of microbiota in vivo. Overall, this comprehensive review aims to provide a new perspective on the effect of NAD+-increasing strategies on host intestinal physiology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeAnimalsHumansNADDysbiosisNiacinamideInflammationMammals

Stichwörter der Autor:innen

agingbiomarkercolitisdiabetes mellitusintestinal bowel diseasemetabolomicsniacinnicotinamidepellagratherapy

Substanzen

NADNiacinamide

Autor:innen und Institutionen

  • Institut d'Investigació Biomèdica Sant Pau (IIB Sant Pau), 08041 Barcelona, Spain.
  • Grupo de Obesidad y Metabolismo, Instituto Murciano de Investigación Biosanitaria (IMIB), 30120 Murcia, Spain.
  • Departamento de Bioquímica y Biología Molecular B e Inmunología, Facultad de Medicina, Universidad de Murcia (UMU), 30120 Murcia, Spain.
  • CIBER de Diabetes y Enfermedades Metabólicas Asociadas, Instituto de Salud Carlos III, 08041 Barcelona, Spain.
  • Department of Endocrinology & Nutrition, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.
  • Department of Endocrinology & Nutrition, Hospital Universitari Germans Trias I Pujol, 08916 Badalona, Spain.

ORCID-Profile: Julia Niño-Narvión, Marina Idalia Rojo-López, Joana Rossell, Antonio J Ruiz-Alcaraz, Bruno Ramos-Molina, Didac Mauricio, Josep Julve

Förderung

  • Instituto de Salud Carlos III
  • Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III (Madrid, Spain)
  • Miguel Servet Type I” program
  • Pla Estratègic de Recerca i Innovació en Salut (PERIS)
  • CIBER-Consorcio Centro de Investigación Biomédica en Red-CIBERDEM

Zitieren

APA

Niño-Narvión, J., Rojo-López, M. I., Martinez-Santos, P., Rossell, J., Ruiz-Alcaraz, A. J., Alonso, N., Ramos-Molina, B., Mauricio, D., & Julve, J. (2023). NAD+ Precursors and Intestinal Inflammation: Therapeutic Insights Involving Gut Microbiota. Nutrients, 15(13), 2992. https://doi.org/10.3390/nu15132992

Vancouver

Niño-Narvión J, Rojo-López MI, Martinez-Santos P, Rossell J, Ruiz-Alcaraz AJ, Alonso N, et al. NAD+ Precursors and Intestinal Inflammation: Therapeutic Insights Involving Gut Microbiota. Nutrients. 2023;15(13):2992. doi:10.3390/nu15132992

BibTeX
@article{NioNarvin2023,
  author = {Niño-Narvión, Julia and Rojo-López, Marina Idalia and Martinez-Santos, Patricia and Rossell, Joana and Ruiz-Alcaraz, Antonio J and Alonso, Núria and Ramos-Molina, Bruno and Mauricio, Didac and Julve, Josep},
  title = {NAD+ Precursors and Intestinal Inflammation: Therapeutic Insights Involving Gut Microbiota},
  journal = {Nutrients},
  year = {2023},
  volume = {15},
  number = {13},
  pages = {2992},
  doi = {10.3390/nu15132992}
}
Kostenlos starten →